Literature DB >> 16168995

Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients.

Stavros Antonopoulos, Sotiris Mikros, Maria Mylonopoulou, Stelios Kokkoris, Gregory Giannoulis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16168995     DOI： 10.1016/j.atherosclerosis.2005.08.021

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  26 in total

1.  Treatment options for nonalcoholic Fatty liver disease.

Authors:  Shivakumar Chitturi
Journal:  Therap Adv Gastroenterol       Date:  2008-11       Impact factor: 4.409

2.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

3.  Current and novel therapies for the treatment of nonalcoholic steatohepatitis.

Authors:  David van der Poorten; Jacob George
Journal:  Hepatol Int       Date:  2007-07-26       Impact factor: 6.047

Review 4.  Modern approach to the clinical management of non-alcoholic fatty liver disease.

Authors:  Maria Del Ben; Licia Polimeni; Francesco Baratta; Daniele Pastori; Lorenzo Loffredo; Francesco Angelico
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

5.  Nonalcoholic fatty liver disease: from lipid profile to treatment.

Authors:  Kouichi Miura; Hirohide Ohnishi
Journal:  Clin J Gastroenterol       Date:  2012-06-17

Review 6.  Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal.

Authors:  Valerio Nobili; Arun J Sanyal
Journal:  J Gastroenterol       Date:  2011-10-08       Impact factor: 7.527

Review 7.  Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.

Authors:  Kareem Hassan; Varun Bhalla; Mohammed Ezz El Regal; H Hesham A-Kader
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 8.  Obstructive sleep apnea syndrome and fatty liver: association or causal link?

Authors:  Mohamed-H Ahmed; Christopher-D Byrne
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

Review 9.  Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review.

Authors:  William Nseir; Mahmud Mahamid
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

Review 10.  Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.

Authors:  Vikas Khullar; Angela Dolganiuc; Roberto J Firpi
Journal:  World J Transplant       Date:  2014-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.